Lee Chan Henry: insider trades.
Lee Chan Henry reported 13 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($2.0M), across 1 company.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Lee Chan Henry
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BeOne Medicines Ltd. (ONC) | Officer · SVP, General Counsel | 13 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-11 | BeOne Medicines Ltd. | S | 2,666 | $360 | 0 | Form 4 |
| 2026-08-11 | BeOne Medicines Ltd. | M | 796 | $159.03 | 2,666 | Form 4 |
| 2026-08-11 | BeOne Medicines Ltd. | M | 1,058 | $213.32 | 1,870 | Form 4 |
| 2026-08-11 | BeOne Medicines Ltd. | M | 812 | $194.47 | 812 | Form 4 |
| 2026-07-30 | BeOne Medicines Ltd. | S | 1,044 | $323.69 | 0 | Form 4 |
| 2026-07-22 | BeOne Medicines Ltd. | S | 1,669 | $325 | 0 | Form 4 |
| 2026-07-22 | BeOne Medicines Ltd. | M | 490 | $159.03 | 1,669 | Form 4 |
| 2026-07-22 | BeOne Medicines Ltd. | M | 665 | $213.32 | 1,179 | Form 4 |
| 2026-07-22 | BeOne Medicines Ltd. | M | 514 | $194.47 | 514 | Form 4 |
| 2026-07-08 | BeOne Medicines Ltd. | M | 266 | $213.32 | 468 | Form 4 |
| 2026-07-08 | BeOne Medicines Ltd. | M | 196 | $159.03 | 664 | Form 4 |
| 2026-07-08 | BeOne Medicines Ltd. | S | 664 | $302.46 | 0 | Form 4 |
| 2026-07-08 | BeOne Medicines Ltd. | M | 202 | $194.47 | 202 | Form 4 |
Questions
What stock did Lee Chan Henry buy or sell?
Lee Chan Henry reported 13 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($2.0M), across 1 company.
Is Lee Chan Henry the same person as other filers with this name?
This page covers SEC CIK 1980648 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lee-chan-henry-1980648.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.